.2.3.  
 
 
Table 7. Weekly prevalence of SARS -CoV-2 VOIs and VUMs by WHO regions, week 48 to week 52 of 2023  
 
 
 
* Includes descendant lineages, except those individually specified elsewhere in the table. For example, XBB* does not includ e 
XBB.1.5, XBB.1.16, EG.5, XBB.1.9.1, XBB.1.9.2, and XBB.2.3.  
¥ due to the small numbers of sequences submitted in these regions, it has not been possible to determine trends for the VOIs  and 
VUMs in these regions; this is also represented by the shaded cells in the table .   
 
 
20 
 Figure 9. Global 28 -day prevalence of EG.5, XBB.1.5, XBB.1.16, BA.2.86, and JN.1, from 11 December 2023 to 7 January  
2024  *+     
 
 
* Reporting period to account for delay in sequence submission to GISAID.  
+ Historical presence indicates countries previously reporting sequences of VOIs but have not reported within the period from 4 
November  to 3 December  2023  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
21 
 Figure 10. The (A) number and (B) percentage of SARS -CoV-2 sequences, from 3 July to 31 December  2023  
 
 
 
 
 
 
   
Figure 10. Panel A  shows the number, and Panel B  the percentage, of all circulating variants since July to December 2023. The variants 
shown here include descendent lineages, except for the descendent lineage(s)